NxStage Medical, Inc. company info

CIK 1333170
IRS Number 043454702
State of incorporation DE
Business address 350 MERRIMACK STREET
None
LAWRENCE
MA
01843
Mail address 350 MERRIMACK STREET
None
LAWRENCE
MA
01843

Short summary

NxStage Medical, Inc. is a Massachusetts company, with head office located at 350 Merrimack Street Lawrence, Massachusetts 01843. In 2017 the company owned a total of 325.35 million USD worth of assets, including 151.93 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

NxStage Medical, Inc. Income Statement

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Gross Profit 36.8658.1377.6192.81102.50115.90131.47151.99
Research and development 9.8112.9014.4417.1118.8922.6426.2431.03
Operating Expenses 73.3184.5993.11104.01120.30138.09146.10156.27
Operating Income (Loss) -36.45-26.46-15.50-11.21-17.80-22.19-14.63-4.29
Interest expense 6.524.604.712.770.61
Other Nonoperating Income (Expense) -0.270.11-0.29-0.15-0.40-0.010.56-0.93
Income Tax Expense (Benefit) 0.270.770.901.03-0.251.251.081.10
Net income -43.47-31.71-21.40-15.15-18.56-23.95-15.34-4.77

NxStage Medical, Inc. Balance Sheet

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Cash and cash equivalents 26.6420.05100.43102.8694.3062.0848.3558.4662.8462.98
Accounts Receivable, Net, Current 15.8917.6420.8431.0926.4030.0931.9030.25
Inventories 39.2134.6739.3543.3543.3741.3151.2350.67
Property, Plant and Equipment, Gross 20.1332.6853.6574.2794.45103.57108.72
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 11.841617.3321.7927.8836.8647.16
Goodwill 42.7042.7042.3141.8241.8242.7142.6542.75
Intangible Assets, Net (Excluding Goodwill) 24.0121.2218.5915.8015.08
Other Assets, Noncurrent 0.682.072.242.572.883.072.975.38
Total assets 196.98291.42302.05312.45312.78301.39313.70328.57325.35
Current assets 158.00157.26159.45141.05124.38135.78155.47151.93
Accounts payable 22.6214.5618.5022.5312.7913.5815.0012.87
Taxes Payable, Current 1.570.821.081.28
Total current liabilities 36.8432.4942.9645.6940.8644.9846.5146.20
Long-term Debt, Excluding Current Maturities 41.821.001.841.600.550.55
Long-term Debt 44.50
Deferred Revenue, Noncurrent 56.0055.6753.4051.8351.7252.2847.6647.42
Total liabilities 140.29106.77115.80122.56112.94115.77112.41112.16
Common Stock, Value, Issued 0.060.060.060.060.060.070.070.07
Retained Earnings (Accumulated Deficit) -319.99-340.04-353.38-375.93-398.47-405.84-410.88-419.32
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.40-0.19-0.090.57-3.12-4.25-1.50-1.90

NxStage Medical, Inc. Cash Flow

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Net income -43.47-31.71-21.40-15.15-18.56-23.95-15.34-4.77
Depreciation and amortization 20.7822.3823.0923.6724.8527.7030.7232.64
Depreciation 3.403.303.403.704.707.1010.4011.60
Amortization of Intangible Assets 2.802.802.802.802.802.602
Deferred Income Tax Expense (Benefit) -0.38-0.22-0.08-0.23-0.17
Accounts receivable 2.21-0.241.773.141.104.191.137.39
Inventories 9.2128.7416.3714.5520.0835.0612.1131.07
Accounts payable 2.57-2.78-1.050.84-2.23-0.21-2.783.53
Deferred revenue 5.0716.881.65-3.99-4.89-0.97-2.35-2.44
Net Cash Provided by (Used in) Operating Activities -13.163.11-1.526.24-10.14-20.2710.544.59
Payments to Acquire Property, Plant, and Equipment 1.731.565.167.6916.2520.1011.548.85
Payments to Acquire Businesses, Net of Cash Acquired 2.23000.51
Net Cash Provided by (Used in) Investing Activities -2.07-1.22-5.16-7.69-18.48-20.10-10.86-9.36
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -7.69-18.48-20.10-10.86
Proceeds from Issuance of Long-term Debt 39.901.1401.280
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures -4.07-5.32-1.17-0.42-0.42-0.94-0.69
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures -4.07-5.32-1.17-0.42-0.42-0.94-0.69
Proceeds from Issuance of Common Stock 73.35
Payments for Repurchase of Common Stock 4.582.530.52
Net Cash Provided by (Used in) Financing Activities 10.0381.165.394.735.769.467.335.28
Cash and Cash Equivalents, Period Increase (Decrease) -4.9282.62-1.433.53-22.31-31.256.180.57